Aktuelle praktische Bedeutung gentechnologischer Entwicklungen

• LITERATUR

• 1 Antonarakis S E, Waber P G, Kittur S D. et al. Detection of molecular defects and of carriers by DNA analysis. N Engl J Med 1985; 313: 842-8.
• 2 Bernardi F, Marchetti G, Bertaguolo G. et al. Two TaqI RFLPs in the human von Willebrand factor gene. Nucl Acid Res 1987; 15: 1347.
• 3 Camerino G, Grzeschik K H, Jaye M. et al. Regional localization on the human X-chromosome and polymorphism of the coagulation factor IX gene (hemophilia B locus). Proc Natl Acad Sci 1984; 81: 498-502.
• 4 Camerino G, Oberle I, Drayna D. et al. A new MspI restriction fragment length polymorphism in the hemophilia B locus. Hum Genet 1985; 71: 79-81.
• 5 Choo K H, Raphael K, McAdam W. et al. Expression of active human blood clotting factor IX in transgenic mice : use of a cDNA with complete mRNa sequence. Nucl Acid Res 1987; 15: 871-84.
• 6 Gitschier J, Wood W I, Goralka T M. et al. Characterisation of the human factor VIII gene. Nature 1984; 312: 326-30.
• 7 Gitschier J, Drayna D, Tuddenham E G D. et al. Genetic mapping and diagnosis of haemophilia A achieved through a Bell polymorphism in the factor VIII gene. Nature 1985; 314: 738-40.
• 8 Harper K, Winter R M, Pembrey M E. et al. A clinically useful DNA probe closely linked to haemophilia A. Lancet 1984; II: 6-8.
• 9 Kannel W B, Castelli W B, Meeks S L. Fibrinogen and cardiovascular disease. Annual Scient Session. Am Coll Cardiol, Anaheim, Calif., Abstr. 1985
• 10 Meade T W, North W R S, Chakrabarti R R. et al. Haemostatic function and cardiovascular death: early results of a prospective study. 1980. Lancet I: 1050-4.
• 11 Meade T W. Haemostatic variables in coronary disease. Int Congr Thromb Haemost, Brussels. 1987
• 12 Moodie P, Liddell M B, Peake I R. et al. Carrier detection in 50 haemophilia A kindred by means of three intragenic and two extragenic restriction fragment length polymorphisms. Br J Haematol 1988; 70: 77-84.
• 13 Oberle I, Drayna D, Camarino G. et al. The telomeric region of the human X-chromosome long arm: presence of a highly polymorphic DNA marker and analysis of recombination frequency. Proc Nat Acad Sci USA 1985; 82: 2824-8.
• 14 Quadt R, Verweij C L, de Vries C J M. et al. A polymorphic Xbal site within the human von Willebrand Factor (vWF) gene. Nucl Acid Res 1986; 14: 7139.
• 15 Stone M C, Thorpe J M. Plasma fibrinogen, a major coronary risk factor. J R Coll Gen Pract 1985; 35: 565-9.
• 16 Toole J J, Knopf J L, Wozney J M. et al. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 1984; 314: 342-7.
• 17 Vehar G A, Keyt B, Eaton D. et al. Structure of human factor VIII. Nature 1984; 314: 337-42.
• 18 Verweij C L, Quadt R, Briet E. et al. Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand’s disease type II A. J Clin Invest 1988; 81: 1116-21.
• 19 Winship P R, Anson D S, Rizza C R, Brownlee G G. Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms. Nucl Acid Res 1984; 12: 8861-71.
• 20 Wion K L, Tuddenham E G D, Lawn R M. A new polymorphism in the factor VIII gene for prenatal diagnosis of hemophilia A. Nucl Acids Res 1986; 14: 4535-42.
• 21 Wood W I, Capon D J, Simonsen C C. et al. Expression of active human factor VIII from recombinant DNA clones. Nature 1984; 312: 330-6.